BN

Bidya Nand Kumar

Active Director Director DIN 08686480
DIN 08686480 First appointment Jan 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value •••• Premium profile

About Bidya Nand Kumar

Data last updated:

Bidya Nand Kumar is a Director at Tds Biotech Private Limited (since 2020). The company operates in Chemicals. Tds Biotech Private Limited reported revenue of ₹29,765 (FY 2024).

DIN 08686480
Primary Designation Director
Industry Chemicals
First Appointment 31 Jan 2020
Oldest Company Age 6 yrs
Largest company Tds Biotech Private Limited · ₹29,765 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tds Biotech Private Limited U24230DL2020PTC361221
Director31 Jan 20202020₹29,765 (FY 2024)Active

Board colleagues of Bidya Nand Kumar

NameDINCompanyDesignation
Sapna Kumari08686481Tds Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tds Biotech Private Limited
Premium access

Shareholding and investment profile for Bidya Nand Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bidya Nand Kumar

Bidya Nand Kumar currently holds 1 directorship: Tds Biotech Private Limited (Director, since 31 Jan 2020, revenue ₹29,765 (FY 2024)).

Bidya Nand Kumar was first appointed on 31 Jan 2020 as Director at Tds Biotech Private Limited.

The current boards of Bidya Nand Kumar's companies include Sapna Kumari (Tds Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available